Li Liu

Li Liu

Auto-generated profile, based on publicly available information

Li Liu

School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, China; Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang 550025, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2022 in Dyes and Pigments
Verified
Journal Article
Closed access
LYLongjia Yan
Longjia Yan
DLDan Li
Dan Li
YLYi Le
Yi Le
PDPing Dong
Ping Dong
LLLi Liu
Li Liu

12 September 2022 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
DLDan Li
Dan Li
STSan Tu
San Tu
YLYi Le
Yi Le
YZYue Zhou
Yue Zhou
LYLan Yang
Lan Yang
LLLi Liu
Li Liu

28 January 2024 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
STSan Tu
San Tu
YLYi Le
Yi Le
LYLan Yang
Lan Yang
QYQiong Yi
Qiong Yi
TFTingting Feng
Tingting Feng
LLLi Liu
Li Liu

9 September 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
STSan Tu
San Tu
DLDan Li
Dan Li
TFTingting Feng
Tingting Feng
YLYi Le
Yi Le
LYLongjia Yan
Longjia Yan
LLLi Liu
Li Liu

13 February 2019 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
TZTingting Zheng
Tingting Zheng
HFHuanhuan Feng
Huanhuan Feng
LLLi Liu
Li Liu
JPJiao Peng
Jiao Peng
HXHaitao Xiao
Haitao Xiao
C.Chen Yun .
Chen Yun .
The present study describes the preparation of a dodecapeptide YHWYGYTPQNVI (GE11)‑conjugated liposome bound with polyethylene glycol to enhance the therapeutic effect of resveratrol (RSV) in head and neck cancer cells. The results indicated that (RSV)‑loaded GE11‑conjugated liposomes (RSV‑GL) exhibited a high entrapment efficiency of >95%, with an active drug loading level of 19.5% w/w. Release kinetics revealed that RSV was released in a slow and sustained manner from the RSV‑GL and RSV‑loaded liposome (RSV‑L) nanoparticulate systems. The epidermal growth factor receptor (EGFR)‑overexpressing squamous cell carcinoma HN cells specifically internalized GE11 surface‑conjugated liposome in a manner that was markedly increased compared with that of the non‑targeted carrier. Consistently, RSV‑GL exhibited a significantly increased cytotoxic effect compared with that of the non‑targeted nanoparticles. Notably, RSV‑GL induced significantly increased proportions of early (~60%) and late (~10%) apoptotic cells in head and neck cancer cell populations. To the best of our knowledge, the application and development of EGFR‑targeted peptide‑conjugated liposome system for RSV delivery has not been studied previously in the treatment of head and neck cancer. In addition, RSV‑GL exhibited the greatest antitumor efficacy compared with any other group. RSV‑GL exhibited a 2‑fold decrease in tumor volume compared with the free RSV and a 3‑fold decrease in volume compared with the control. Overall, the nanomedicine strategy described in the present study may potentially advance the chemotherapy‑based treatment of head and neck cancer, with promising applications in other EGFR‑overexpressing tumors.

5 June 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
YDYuyu Ding
Yuyu Ding
YZYan Zhang
Yan Zhang
LYLongjia Yan
Longjia Yan
LLLi Liu
Li Liu